Cargando…

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients

Detalles Bibliográficos
Autores principales:	van Geelen, Courtney T., Savas, Peter, Teo, Zhi Ling, Luen, Stephen J., Weng, Chen-Fang, Ko, Yi-An, Kuykhoven, Keilly S., Caramia, Franco, Salgado, Roberto, Francis, Prudence A., Dawson, Sarah-Jane, Fox, Stephen B., Fellowes, Andrew, Loi, Sherene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284837/ https://www.ncbi.nlm.nih.gov/pubmed/35841108 http://dx.doi.org/10.1186/s13058-022-01539-7

Ejemplares similares

Clinical implications of prospective genomic profiling of metastatic breast cancer patients
por: van Geelen, Courtney T., et al.
Publicado: (2020)

Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study
por: Zivanovic Bujak, Andjelija, et al.
Publicado: (2020)

The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE”
por: Savas, Peter, et al.
Publicado: (2016)

Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE"
por: Savas, Peter, et al.
Publicado: (2017)

Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
por: Teo, Zhi Ling, et al.
Publicado: (2023)

Checkpoint blockade in the treatment of breast cancer: current status and future directions
por: Wein, Lironne, et al.
Publicado: (2018)

Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions
por: Wein, Lironne, et al.
Publicado: (2017)

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
por: Luen, Stephen L., et al.
Publicado: (2019)

Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
por: Dushyanthen, Sathana, et al.
Publicado: (2017)

Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions
por: David, Steven, et al.
Publicado: (2022)

Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data
por: Lönnstedt, Ingrid M, et al.
Publicado: (2014)

Relevance of tumor-infiltrating lymphocytes in breast cancer
por: Dushyanthen, Sathana, et al.
Publicado: (2015)

Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials
por: Cui, Wanyuan, et al.
Publicado: (2022)

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
por: Loi, Sherene
Publicado: (2013)

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
por: David, Steven, et al.
Publicado: (2019)

Triple-negative breast cancer: recent treatment advances
por: Bergin, Alice R T, et al.
Publicado: (2019)

Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 update()
por: Brown, Lauren C., et al.
Publicado: (2021)

Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?
por: Dixon-Douglas, Julia, et al.
Publicado: (2023)

Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer
por: Rohan, Thomas E., et al.
Publicado: (2021)

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data
por: Zardavas, Dimitrios, et al.
Publicado: (2014)

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
por: Criscitiello, Carmen, et al.
Publicado: (2010)

Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context
por: Abraham, Gad, et al.
Publicado: (2010)

Canary: an atomic pipeline for clinical amplicon assays
por: Doig, Kenneth D., et al.
Publicado: (2017)

Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics
por: Doig, Kenneth D., et al.
Publicado: (2022)

Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)
por: Tovey, Holly, et al.
Publicado: (2023)

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
por: Loi, Sherene, et al.
Publicado: (2022)

Symptom modelling can be influenced by psychiatric categories: choices for research domain criteria (RDoC)
por: Fellowes, Sam
Publicado: (2017)

How autism shows that symptoms, like psychiatric diagnoses, are 'constructed': methodological and epistemic consequences
por: Fellowes, Sam
Publicado: (2021)

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer
por: Turner, Nicholas C., et al.
Publicado: (2019)

Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays
por: Jose, Vinu, et al.
Publicado: (2018)

Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol
por: Foulkes, Stephen J., et al.
Publicado: (2020)

Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer
por: Rogers, Toni-Maree, et al.
Publicado: (2017)

Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis
por: Caparica, Rafael, et al.
Publicado: (2021)

Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report
por: Williams, Scott G., et al.
Publicado: (2020)

Establishing the Link between X-Chromosome Aberrations and TP53 Status, with Breast Cancer Patient Outcomes
por: Caramia, Franco, et al.
Publicado: (2023)

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer
por: Jimeno, Rebeca, et al.
Publicado: (2022)

EFFECT OF DEHYDROASCORBIC ACID ON THE ISLETS OF LANGERHANS OF THE RAT PANCREAS
por: Merlini, Dino, et al.
Publicado: (1965)

Consumption of Eggs Alone or Enriched with Annatto (Bixa orellana L.) Does Not Increase Cardiovascular Risk in Healthy Adults—A Randomized Clinical Trial, the Eggant Study
por: Galvis, Yeisson, et al.
Publicado: (2023)

William Byrd
por: Fellowes, Edmund Horace, 1870-1951
Publicado: (1948)

Simulating chalcogen bonding using molecular mechanics: a pseudoatom approach to model ebselen
por: Fellowes, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gtee413l71feb2hr19bc97ioqr